Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on healthcare costs

Dworkin, Robert H.; Panarites, Christopher J.; Chen, J.

doi:10.1016/j.jpain.2009.01.075

Cited by 5 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The choice of algorithms was made according to the most prevalent chronic pain syndromes in the QPR (Table ). Although previous administrative database studies reported algorithms for postherpetic neuralgia, osteoarthritis, migraine, headaches, rheumatoid arthritis, irritable bowel syndrome, and systemic lupus erythematous, the prevalence of such conditions was ≤2.5% in our sample (Table ) and did not allow us to estimate validity statistics. The validity of single pain codes (307.8, 338, 338.2, or 338.4) was also investigated (end of Table ).…”

Section: Methodsmentioning

confidence: 69%

Is the Quebec provincial administrative database a valid source for research on chronic non‐cancer pain?

Lacasse

Ware

Dorais³

et al. 2015

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

show abstract

Section: Methodsmentioning

confidence: 69%

Is the Quebec provincial administrative database a valid source for research on chronic non‐cancer pain?

Lacasse

Ware

Dorais³

et al. 2015

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

show abstract

“…Dworkin et al calculated the cost for painful diabetic peripheral neuropathy at 6.2 thousand USD per patient, which is even higher than the average costs for DM treatment [ 14 ].…”

Section: Resultsmentioning

confidence: 99%

Associations of diabetic retinopathy with retinal neurodegeneration on the background of diabetes mellitus. Overview of recent medical studies with an assessment of the impact on healthcare systems

2018

View full text Add to dashboard Cite

AbstractDiabetes Mellitus (DM) is one of the biggest healthcare and financial problems worldwide. The disease is strongly associated with microvascular and macrovascular complications, causing co-existing diseases like Diabetic Retinopathy, Diabetic Neuropathy and Diabetic Nephropathy. Annual healthcare expenditures for diabetes treatment and complications prevention cost 727 billion USD in year 2017.Diabetes Mellitus, Diabetic Retinopathy and Diabetic Retinal Neuropathy are closely related diseases - originating from incorrectly controlled glycemia, blood pressure and lipid levels in the course of increasing resistance of the body tissues to insulin.Irrespectively of thorough programs for Diabetes Mellitus prevention and treatment, Diabetic Retinopathy management requires targeted treatment strategies for both microvasculopathy and retinal neurodegeneration, to delay disease severity course and risk of blindness.The study and conclusions in this article are based on web-available data and officially published articles related to the diabetes mellitus and associated diseases – Diabetic Retinopathy and Diabetic Retinal Neuropathy. The articles have been reviewed and analyzed to assess mutual relations between the discussed diseases.

show abstract